News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,295 Results
Type
Article (42328)
Company Profile (266)
Press Release (675701)
Multimedia
Podcasts (91)
Webinars (13)
Section
Business (209346)
Career Advice (2314)
Deals (36136)
Drug Delivery (107)
Drug Development (81540)
Employer Resources (186)
FDA (16425)
Job Trends (15424)
News (352796)
Policy (33543)
Tag
Academia (2628)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (50926)
ALS (96)
Alzheimer's disease (1404)
Antibody-drug conjugate (ADC) (137)
Approvals (16423)
Artificial intelligence (288)
Autoimmune disease (24)
Automation (17)
Bankruptcy (364)
Best Places to Work (11915)
BIOSECURE Act (20)
Biosimilars (109)
Biotechnology (188)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (293)
Cancer (2338)
Cardiovascular disease (184)
Career advice (1940)
Career pathing (32)
CAR-T (162)
Cell therapy (449)
Cervical cancer (20)
Clinical research (66413)
Collaboration (878)
Company closure (2)
Compensation (572)
Complete response letters (19)
COVID-19 (2622)
CRISPR (42)
C-suite (261)
Cystic fibrosis (104)
Data (2343)
Decentralized trials (2)
Denatured (38)
Depression (46)
Diabetes (278)
Diagnostics (6511)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (122)
Drug pricing (118)
Drug shortages (28)
Duchenne muscular dystrophy (97)
Earnings (87721)
Editorial (44)
Employer branding (23)
Employer resources (156)
Events (116230)
Executive appointments (775)
FDA (17830)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (794)
Gene editing (112)
Generative AI (24)
Gene therapy (322)
GLP-1 (744)
Government (4567)
Grass and pollen (4)
Guidances (162)
Healthcare (19218)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (126)
Indications (30)
Infectious disease (2771)
Inflammatory bowel disease (144)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (100)
Interviews (377)
IPO (16670)
IRA (49)
Job creations (3917)
Job search strategy (1648)
Kidney cancer (10)
Labor market (46)
Layoffs (490)
Leadership (22)
Legal (8181)
Liver cancer (76)
Lung cancer (328)
Lymphoma (157)
Machine learning (9)
Management (61)
Manufacturing (346)
MASH (78)
Medical device (13655)
Medtech (13660)
Mergers & acquisitions (20049)
Metabolic disorders (724)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (95)
Neuropsychiatric disorders (28)
Neuroscience (1971)
NextGen: Class of 2025 (6786)
Non-profit (4579)
Now hiring (40)
Obesity (382)
Opinion (250)
Ovarian cancer (82)
Pain (92)
Pancreatic cancer (88)
Parkinson's disease (155)
Partnered (22)
Patents (249)
Patient recruitment (116)
Peanut (46)
People (59713)
Pharmaceutical (64)
Pharmacy benefit managers (21)
Phase I (20691)
Phase II (29251)
Phase III (21792)
Pipeline (1391)
Policy (166)
Postmarket research (2589)
Preclinical (8822)
Press Release (68)
Prostate cancer (108)
Psychedelics (31)
Radiopharmaceuticals (252)
Rare diseases (393)
Real estate (6231)
Recruiting (69)
Regulatory (22959)
Reports (52)
Research institute (2407)
Resumes & cover letters (387)
Rett syndrome (6)
RNA editing (5)
RSV (44)
Schizophrenia (74)
Series A (136)
Series B (91)
Service/supplier (12)
Sickle cell disease (52)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (31)
Startups (3713)
State (2)
Stomach cancer (13)
Supply chain (72)
Tariffs (57)
The Weekly (51)
Vaccines (711)
Venture capitalists (43)
Weight loss (249)
Women's health (39)
Worklife (18)
Date
Today (124)
Last 7 days (1005)
Last 30 days (3290)
Last 365 days (32883)
2025 (12170)
2024 (35732)
2023 (40636)
2022 (51755)
2021 (56287)
2020 (54941)
2019 (47909)
2018 (36159)
2017 (33058)
2016 (32573)
2015 (38540)
2014 (32268)
2013 (27333)
2012 (29728)
2011 (30314)
2010 (28275)
Location
Africa (796)
Alabama (54)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (39882)
Australia (6453)
California (6487)
Canada (2085)
China (552)
Colorado (279)
Connecticut (289)
Delaware (161)
Europe (85281)
Florida (962)
Georgia (221)
Idaho (59)
Illinois (574)
India (25)
Indiana (328)
Iowa (11)
Japan (174)
Kansas (109)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (938)
Massachusetts (4844)
Michigan (229)
Minnesota (409)
Mississippi (2)
Missouri (83)
Montana (29)
Nebraska (25)
Nevada (68)
New Hampshire (68)
New Jersey (1808)
New Mexico (29)
New York (1828)
North Carolina (1029)
North Dakota (8)
Northern California (2865)
Ohio (220)
Oklahoma (14)
Oregon (35)
Pennsylvania (1439)
Puerto Rico (13)
Rhode Island (34)
South America (1209)
South Carolina (27)
South Dakota (1)
Southern California (2434)
Tennessee (107)
Texas (967)
United States (24412)
Utah (195)
Virginia (154)
Washington D.C. (66)
Washington State (571)
West Virginia (3)
Wisconsin (59)
718,295 Results for "sceptor industries inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Diversity at the Forefront: Life Sciences Industry Champions Inclusive Representation
The industry remains unwavering in the commitment to increased clinical trial accessibility and representation.
February 25, 2025
·
1 min read
·
Lori Ellis
Press Releases
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
April 1, 2025
·
5 min read
FDA
FDA Moves to Restrict Industry Influence on Advisory Committees
Industry representatives will still be allowed at these meetings, but they will no longer have a spot on the advisory committee.
April 18, 2025
·
2 min read
·
Tristan Manalac
Government
HHS Secretary Kennedy Accuses FDA Employees of Being Industry ‘Sock Puppet’
Leerink analysts warned that Kennedy’s remarks to FDA staff would likely be a negative for the biotech industry.
April 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
·
3 min read
·
BioSpace Editorial Staff
FDA
Banning Industry From FDA Adcomms Won’t ‘Move the Needle Much’ in Makary, RFK’s Fight Against COIs
FDA Commissioner Marty Makary last week announced a directive that would limit industry participation in the agency’s advisory committees. But not only do company reps serve only as non-voting members, a 1997 law actually requires industry involvement.
April 21, 2025
·
5 min read
·
Heather McKenzie
In partnership with GenScript
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.
April 14, 2025
·
6 min read
·
BioSpace Insights
Press Releases
QuantHealth Unveils The Industry’s First Pharmaco-Clinical Foundation Model Focused on Clinical Applications of AI in Life Sciences
May 9, 2025
·
4 min read
Pharm Country
Scientific Industries Announces Industry Veteran, John Nicols, as New Board Member and Chairman of Scientific Bioprocessing Inc.
Scientific Industries, Inc. announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc., effective March 4, 2024.
March 8, 2024
·
4 min read
1 of 71,830
Next
